Mindpeak transforms tissue into high-dimensional data, enabling the discovery and deployment of AI-driven biomarkers that guide targeted therapies and power precision medicine. The company bridges pathology and drug development to help pharmaceutical partners identify the right patients, accelerate clinical trials, and bring targeted therapies to market.

We develop clinical and research AI solutions for biopharma and diagnostic laboratories. Our platform and products (Phenoscout AI, peakDiscover, peakPredict, peakDeploy, peakAcademy, peakDx, peakDissect) decode complex biological patterns from standard tissue images to predict therapy response, standardize multi-modal analysis, and preserve specimens for downstream molecular testing.

Headquartered in Hamburg, Germany, with an office in Cambridge, MA, USA. Founded in 2018. Mindpeak focuses on regulatory-aware, clinically deployable technology (CE‑IVD products and ISO 13485 quality management) while noting some products may be intended for Research Use Only unless otherwise stated.